Neurogene
NGNE
NGNE
31 hedge funds and large institutions have $14.4M invested in Neurogene in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 10
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
31
Holding in Top 10
–
Calls
$14K
Puts
–
Top Buyers
| 1 | +$1.81M | |
| 2 | +$1.22M | |
| 3 | +$1.18M | |
| 4 |
BCM
BML Capital Management
Zionsville,
Indiana
|
+$371K |
| 5 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$98.4K |
Top Sellers
| 1 | -$2.57M | |
| 2 | -$715K | |
| 3 | -$332K | |
| 4 |
Morgan Stanley
New York
|
-$224K |
| 5 |
PFMU
Privium Fund Management (UK)
London,
United Kingdom
|
-$94.9K |